Beurskoers UCB
UCB nieuws :
Brussels, Belgium and Parsippany, USA – July 7, 2020 (7:00 p.m. CET and 1:00 p.m. ET) – UCB and Ferring Pharmaceuticals Inc. today announced they have entered into a co-promotion agreement to commercialize the prefilled syringe formulation of CIMZIA® (certolizumab pegol) in the United States, specifically for the treatment of Crohn’s disease (CD). Ferring will take over marketing, sales promotion, and field medical affairs activities. UCB will continue to be responsible for all product-related activities, including revenue recognition. CIMZIA is an injectable biologic treatment option for adults with moderate to severe Crohn’s disease with inadequate response to conventional therapy. UCB will continue to promote and to commercialize the lyophilized formulation of CIMZIA for all indications as well as the prefilled syringe formulation for CIMZIA’s rheumatology and dermatology indications.
bron : www.ucb.com/stories-media/Press-Relea... .
Op 27 juli publiceert UCB halfjaarcijfers waarin fors wordt uitgekeken naar het potentiële nieuwe goudhaantje bimekizmab.
afgelopen vrijdag nabeurs ; UCB schrapt weer aandelen : www.ucb.com/stories-media/Press-Relea... .
17 juli nabeurs : nog een rondje aandelen naar het personeel door gebruik van personeelsopties :
www.ucb.com/stories-media/Press-Relea... .
UCB-enters-into-collaboration-with-Roche-to-develop-antibody-treatment-for-people-living-with-Alzheimer-s-Disease
www.ucb.com/stories-media/Press-Relea...
UCB verlengt het inkoopprogramma van eigen aandelen tot 30 september :
Under this program, UCB has requested a financial intermediary to repurchase up to 1.2 million UCB shares on its behalf under the terms of an initial discretionary mandate agreement with initial validity until 15 June 2020, effective as from 25 March 2020, to cover current and future obligations under UCB's Long Term Incentive Plans for its personnel. The validity of this agreement has first been extended from 15 June 2020 to 29 July 2020 and now from 29 July 2020 to 30 September 2020.
In the framework of this Share Repurchase Program 2020, UCB repurchased 70 027 UCB shares on Euronext Brussels in the period from 19 June 2020 up to and including 30 July 2020, as follows:
bron : www.ucb.com/stories-media/Press-Relea... .
Direct naar Forum
Detail
| Vertraagd |
3 aug 2020 17:35 |
| Koers |
108,150 |
| Verschil |
-0,700 (-0,64%) |
| Hoog |
109,150 |
| Laag |
106,200 |
| Volume |
490.344 |
| Volume gemiddeld |
467.687 |
| Volume gisteren |
689.650 |